Clinical Ethics & Accountability in health Records AI

AI in Healthcare Unleashed: Responsible and Ethical Implementation of Large Language Model Chatbots in Clinical Workflows and Patient Care

Since the launch of OpenAI's ChatGPT in November 2022, this AI has hit the headlines. ChatGPT, a generative AI Large Language Model (LLM), can summarize data and generate responses in various styles. In healthcare, these tools could offer many benefits such as helping doctors with documentation and diagnoses. However, LLMs can also introduce errors and biases, and may risk patient privacy. This project specifically explores how LLMs might assist with documentation and patient support.

The project has 3 aims:

AIM 1: To investigate Swedish doctors’ and nurses’ experiences & understanding of LLMs in documentation in clinical practice.

AIM 2: To investigate patients’ experiences & understanding of LLMs in interpreting their health data.

AIM 3: To investigate how healthcare might ethically & safely adopt these tools to benefit healthcare professionals & patients

Why this project is important

In December 2023, the EU made history by proposing the first-ever rules for LLM chatbots, requiring AI makers to ensure users know they're interacting with AI. But here's the catch: we still don’t know when or how healthcare professionals and patients are using these tools, or how to ethically, safely, and effectively integrate LLMs into healthcare. That’s the challenge we need to tackle.

In previous studies that made national and international headlines, members of the research team discovered that more than 1 in 3 US psychiatrists, and 1 in 5 UK GPs reported using generative AI to assist with clinical tasks.

The current project aims to advance this research within Sweden by expanding the investigation to nationally representative doctors and nurses, across all specialties and by asking patients for their experiences and opinions about these tools.

Contact

If you have questions or are interested in participating in the project, contact the principal investigator Charlotte Blease